ANALYTICA LIMITED - Announcements

Currently unlisted. Add to my watchlist

Analytica Limited is engaged in the design, development and supply of Class I and II... Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

ALT	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	27/02/19		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19		Share
ALT	Shareholder Update on US Sales Capability	PRICE SENSITIVE	18/12/18		Share
ALT	CEO presentation to AGM	PRICE SENSITIVE	22/11/18		Share
ALT	Chairman's Address to Shareholders	PRICE SENSITIVE	22/11/18		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/18		Share
ALT	Appendix 4E and Annual Report	PRICE SENSITIVE	30/08/18		Share
ALT	PeriCoach Real World Data Analysis Statistically Significant	PRICE SENSITIVE	21/08/18		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/18		Share
ALT	Exercise of unlisted options and placement	PRICE SENSITIVE	12/06/18	103.17KB	Share
ALT	TGA clearnance to assist treatment of Pelvic Organ Prolapse	PRICE SENSITIVE	02/05/18		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18		Share
ALT	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/18		Share
ALT	Suspension from Official Quotation - ALTOA	PRICE SENSITIVE	26/02/18		Share
ALT	Analytica Senate Committee Submission	PRICE SENSITIVE	30/01/18		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/18		Share
ALT	Appointment of Navigant Capital Advisors	PRICE SENSITIVE	06/11/17		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/17		Share
ALT	Replacement Prospectus	PRICE SENSITIVE	26/09/17		Share
ALT	Renounceable Issue	PRICE SENSITIVE	18/09/17		Share
ALT	Appendix 4E and financial statements	PRICE SENSITIVE	31/08/17		Share
ALT	Response to Appendix 4C Query	PRICE SENSITIVE	09/08/17		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/17		Share
ALT	PeriCoach granted patent protection in Australia	PRICE SENSITIVE	11/05/17		Share
ALT	PeriCoach structured exercise program released	PRICE SENSITIVE	04/05/17		Share
ALT	Release of PeriCoach Version 3	PRICE SENSITIVE	01/05/17		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17		Share
ALT	Appendix 4D andf half year accounts	PRICE SENSITIVE	28/02/17		Share
ALT	Pericoach granted Japanese Patent	PRICE SENSITIVE	22/02/17		Share
ALT	Positive clinical trial results for Pericoach	PRICE SENSITIVE	21/02/17		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17		Share
ALT	Placement	PRICE SENSITIVE	31/01/17		Share
ALT	PeriCoach Post Market Survey FIndings	PRICE SENSITIVE	13/01/17		Share
ALT	Research and Development Tax incentive received	PRICE SENSITIVE	22/12/16		Share
ALT	Appendix 4C - quarterly-ALT.AX	PRICE SENSITIVE	28/10/16		Share
ALT	Appendix 4E-ALT.AX	PRICE SENSITIVE	31/08/16		Share
ALT	PeriCoach granted patent protection in China-ALT.AX	PRICE SENSITIVE	03/08/16		Share
ALT	PeriCoach sexual health indication clarification from USFDA-ALT.AX	PRICE SENSITIVE	29/07/16		Share
ALT	Appendix 4C - quarterly-ALT.AX	PRICE SENSITIVE	28/07/16		Share
ALT	Share Placement of $500k to cornerstone investor-ALT.AX	PRICE SENSITIVE	27/07/16		Share
ALT	AutoStart Burette granted US Patent-ALT.AX	PRICE SENSITIVE	15/07/16		Share
ALT	FDA Over the Counter clearance for Pericoach received-ALT.AX	PRICE SENSITIVE	12/07/16		Share
ALT	AutoStart Burette listed through QLD Health tender-ALT.AX	PRICE SENSITIVE	03/06/16		Share
ALT	Appendix 4C - quarterly-ALT.AX	PRICE SENSITIVE	29/04/16		Share
ALT	Capital raising	PRICE SENSITIVE	18/03/16		Share
ALT	Expenditure reduction initatives	PRICE SENSITIVE	10/03/16		Share
ALT	Half Year Accounts and Appendix 4D	PRICE SENSITIVE	29/02/16		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16		Share
ALT	$1.9m Reseach tax incentive received	PRICE SENSITIVE	18/01/16		Share
ALT	Pericoach sexual function feedback	PRICE SENSITIVE	23/11/15		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15		Share
ALT	US Sales Force and Appendix 3B	PRICE SENSITIVE	28/09/15		Share
ALT	Appendix 4E	PRICE SENSITIVE	31/08/15		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15		Share
ALT	Media Speculation	PRICE SENSITIVE	30/07/15		Share
ALT	Renounceable Issue	PRICE SENSITIVE	14/07/15		Share
ALT	Partial Underwriting of Offer and revised offer timetable	PRICE SENSITIVE	13/07/15		Share
ALT	Capital Raising	PRICE SENSITIVE	08/07/15		Share
ALT	Response to Price Query	PRICE SENSITIVE	06/07/15		Share
ALT	Trading Halt	PRICE SENSITIVE	06/07/15		Share
ALT	US distributor appointed	PRICE SENSITIVE	01/07/15		Share
ALT	Pericoach Sales Update	PRICE SENSITIVE	04/06/15		Share
ALT	Response to Price Query	PRICE SENSITIVE	26/05/15		Share
ALT	Response to Appendix 4C Query	PRICE SENSITIVE	13/05/15		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15		Share
ALT	Pericoach clinical trial commences recruitment	PRICE SENSITIVE	16/04/15		Share
ALT	PeriCoach USA 510k clearance received	PRICE SENSITIVE	19/03/15		Share
ALT	Appendix 4d half year report and accounts	PRICE SENSITIVE	27/02/15		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15		Share
ALT	Pericoach Release Update	PRICE SENSITIVE	13/11/14		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14		Share
ALT	Pericoach Clinical Trial preparation	PRICE SENSITIVE	29/10/14		Share
ALT	Receipt of R and D tax redate $989k	PRICE SENSITIVE	24/10/14		Share
ALT	MOU signed with Sportsmed Global	PRICE SENSITIVE	13/10/14		Share
ALT	CE Mark approval granted for PeriCoach	PRICE SENSITIVE	09/10/14		Share
ALT	Entitlement offer and investor presentation	PRICE SENSITIVE	08/10/14		Share
ALT	Reinstatement to Official Quotation	PRICE SENSITIVE	03/10/14		Share
ALT	Capital Raising	PRICE SENSITIVE	03/10/14		Share
ALT	Suspension from Official Quotation	PRICE SENSITIVE	30/09/14		Share
ALT	Trading Halt	PRICE SENSITIVE	29/09/14		Share
ALT	PeriCoach Marketing Update	PRICE SENSITIVE	17/09/14		Share
ALT	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	29/08/14		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14		Share
ALT	Pericoach Controlled Market Release Update	PRICE SENSITIVE	02/07/14		Share
ALT	Pericoarch production commenced	PRICE SENSITIVE	29/05/14		Share
ALT	PeriCoach Update	PRICE SENSITIVE	23/05/14		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/14		Share
ALT	Entitlement Offer	PRICE SENSITIVE	24/04/14		Share
ALT	Capital Raising	PRICE SENSITIVE	22/04/14		Share
ALT	Trading Halt	PRICE SENSITIVE	16/04/14		Share
ALT	Product Development Update	PRICE SENSITIVE	31/03/14		Share
ALT	Appendix 4D and Half Year financial report	PRICE SENSITIVE	28/02/14		Share
ALT	CEO appointment	PRICE SENSITIVE	12/02/14		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14		Share
ALT	TGA registration received from TGA for PeriCoach System	PRICE SENSITIVE	13/11/13		Share
ALT	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/13		Share
ALT	R and D tax incentive refund received - $514k	PRICE SENSITIVE	24/10/13		Share
ALT	First PeriCoach Production	PRICE SENSITIVE	22/10/13		Share
ALT	Underwritten Share Purchase Plan	PRICE SENSITIVE	27/09/13		Share
ALT	Trading Halt	PRICE SENSITIVE	25/09/13		Share

ALT Appendix 4D and Half Year Accounts
27/02/19	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE		Share
ALT Shareholder Update on US Sales Capability
18/12/18	PRICE SENSITIVE		Share
ALT CEO presentation to AGM
22/11/18	PRICE SENSITIVE		Share
ALT Chairman's Address to Shareholders
22/11/18	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/10/18	PRICE SENSITIVE		Share
ALT Appendix 4E and Annual Report
30/08/18	PRICE SENSITIVE		Share
ALT PeriCoach Real World Data Analysis Statistically Significant
21/08/18	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/07/18	PRICE SENSITIVE		Share
ALT Exercise of unlisted options and placement
12/06/18	PRICE SENSITIVE	103.17KB	Share
ALT TGA clearnance to assist treatment of Pelvic Organ Prolapse
02/05/18	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE		Share
ALT Appendix 4D and Half Year Report
28/02/18	PRICE SENSITIVE		Share
ALT Suspension from Official Quotation - ALTOA
26/02/18	PRICE SENSITIVE		Share
ALT Analytica Senate Committee Submission
30/01/18	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
29/01/18	PRICE SENSITIVE		Share
ALT Appointment of Navigant Capital Advisors
06/11/17	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/10/17	PRICE SENSITIVE		Share
ALT Replacement Prospectus
26/09/17	PRICE SENSITIVE		Share
ALT Renounceable Issue
18/09/17	PRICE SENSITIVE		Share
ALT Appendix 4E and financial statements
31/08/17	PRICE SENSITIVE		Share
ALT Response to Appendix 4C Query
09/08/17	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/07/17	PRICE SENSITIVE		Share
ALT PeriCoach granted patent protection in Australia
11/05/17	PRICE SENSITIVE		Share
ALT PeriCoach structured exercise program released
04/05/17	PRICE SENSITIVE		Share
ALT Release of PeriCoach Version 3
01/05/17	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE		Share
ALT Appendix 4D andf half year accounts
28/02/17	PRICE SENSITIVE		Share
ALT Pericoach granted Japanese Patent
22/02/17	PRICE SENSITIVE		Share
ALT Positive clinical trial results for Pericoach
21/02/17	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE		Share
ALT Placement
31/01/17	PRICE SENSITIVE		Share
ALT PeriCoach Post Market Survey FIndings
13/01/17	PRICE SENSITIVE		Share
ALT Research and Development Tax incentive received
22/12/16	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly-ALT.AX
28/10/16	PRICE SENSITIVE		Share
ALT Appendix 4E-ALT.AX
31/08/16	PRICE SENSITIVE		Share
ALT PeriCoach granted patent protection in China-ALT.AX
03/08/16	PRICE SENSITIVE		Share
ALT PeriCoach sexual health indication clarification from USFDA-ALT.AX
29/07/16	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly-ALT.AX
28/07/16	PRICE SENSITIVE		Share
ALT Share Placement of $500k to cornerstone investor-ALT.AX
27/07/16	PRICE SENSITIVE		Share
ALT AutoStart Burette granted US Patent-ALT.AX
15/07/16	PRICE SENSITIVE		Share
ALT FDA Over the Counter clearance for Pericoach received-ALT.AX
12/07/16	PRICE SENSITIVE		Share
ALT AutoStart Burette listed through QLD Health tender-ALT.AX
03/06/16	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly-ALT.AX
29/04/16	PRICE SENSITIVE		Share
ALT Capital raising
18/03/16	PRICE SENSITIVE		Share
ALT Expenditure reduction initatives
10/03/16	PRICE SENSITIVE		Share
ALT Half Year Accounts and Appendix 4D
29/02/16	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE		Share
ALT $1.9m Reseach tax incentive received
18/01/16	PRICE SENSITIVE		Share
ALT Pericoach sexual function feedback
23/11/15	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE		Share
ALT US Sales Force and Appendix 3B
28/09/15	PRICE SENSITIVE		Share
ALT Appendix 4E
31/08/15	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE		Share
ALT Media Speculation
30/07/15	PRICE SENSITIVE		Share
ALT Renounceable Issue
14/07/15	PRICE SENSITIVE		Share
ALT Partial Underwriting of Offer and revised offer timetable
13/07/15	PRICE SENSITIVE		Share
ALT Capital Raising
08/07/15	PRICE SENSITIVE		Share
ALT Response to Price Query
06/07/15	PRICE SENSITIVE		Share
ALT Trading Halt
06/07/15	PRICE SENSITIVE		Share
ALT US distributor appointed
01/07/15	PRICE SENSITIVE		Share
ALT Pericoach Sales Update
04/06/15	PRICE SENSITIVE		Share
ALT Response to Price Query
26/05/15	PRICE SENSITIVE		Share
ALT Response to Appendix 4C Query
13/05/15	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE		Share
ALT Pericoach clinical trial commences recruitment
16/04/15	PRICE SENSITIVE		Share
ALT PeriCoach USA 510k clearance received
19/03/15	PRICE SENSITIVE		Share
ALT Appendix 4d half year report and accounts
27/02/15	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE		Share
ALT Pericoach Release Update
13/11/14	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE		Share
ALT Pericoach Clinical Trial preparation
29/10/14	PRICE SENSITIVE		Share
ALT Receipt of R and D tax redate $989k
24/10/14	PRICE SENSITIVE		Share
ALT MOU signed with Sportsmed Global
13/10/14	PRICE SENSITIVE		Share
ALT CE Mark approval granted for PeriCoach
09/10/14	PRICE SENSITIVE		Share
ALT Entitlement offer and investor presentation
08/10/14	PRICE SENSITIVE		Share
ALT Reinstatement to Official Quotation
03/10/14	PRICE SENSITIVE		Share
ALT Capital Raising
03/10/14	PRICE SENSITIVE		Share
ALT Suspension from Official Quotation
30/09/14	PRICE SENSITIVE		Share
ALT Trading Halt
29/09/14	PRICE SENSITIVE		Share
ALT PeriCoach Marketing Update
17/09/14	PRICE SENSITIVE		Share
ALT Appendix 4E - Preliminary Final Report
29/08/14	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE		Share
ALT Pericoach Controlled Market Release Update
02/07/14	PRICE SENSITIVE		Share
ALT Pericoarch production commenced
29/05/14	PRICE SENSITIVE		Share
ALT PeriCoach Update
23/05/14	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
30/04/14	PRICE SENSITIVE		Share
ALT Entitlement Offer
24/04/14	PRICE SENSITIVE		Share
ALT Capital Raising
22/04/14	PRICE SENSITIVE		Share
ALT Trading Halt
16/04/14	PRICE SENSITIVE		Share
ALT Product Development Update
31/03/14	PRICE SENSITIVE		Share
ALT Appendix 4D and Half Year financial report
28/02/14	PRICE SENSITIVE		Share
ALT CEO appointment
12/02/14	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/01/14	PRICE SENSITIVE		Share
ALT TGA registration received from TGA for PeriCoach System
13/11/13	PRICE SENSITIVE		Share
ALT Appendix 4C - quarterly
31/10/13	PRICE SENSITIVE		Share
ALT R and D tax incentive refund received - $514k
24/10/13	PRICE SENSITIVE		Share
ALT First PeriCoach Production
22/10/13	PRICE SENSITIVE		Share
ALT Underwritten Share Purchase Plan
27/09/13	PRICE SENSITIVE		Share
ALT Trading Halt
25/09/13	PRICE SENSITIVE		Share

REFRESH

ANALYTICA LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available